These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 7913390)
1. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Matsuoka N; Maeda N; Yamaguchi I; Satoh M Brain Res; 1994 Apr; 642(1-2):11-9. PubMed ID: 7913390 [TBL] [Abstract][Full Text] [Related]
2. Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks. Matsuoka N; Maeda N; Yamazaki M; Ohkubo Y; Yamaguchi I J Pharmacol Exp Ther; 1992 Nov; 263(2):436-44. PubMed ID: 1432682 [TBL] [Abstract][Full Text] [Related]
3. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze. Yamazaki M; Matsuoka N; Maeda N; Kuratani K; Ohkubo Y; Yamaguchi I J Pharmacol Exp Ther; 1995 Jan; 272(1):256-63. PubMed ID: 7815340 [TBL] [Abstract][Full Text] [Related]
4. A screening concept based on a hypothesis led to the development of a putative cognitive enhancer that stimulates penile erection. Maeda N; Matsuoka N; Yamazaki M; Arakawa H; Ohkubo Y; Yamaguchi I Jpn J Pharmacol; 1994 Mar; 64(3):147-53. PubMed ID: 8022116 [TBL] [Abstract][Full Text] [Related]
5. Role of somatostatin in the augmentation of hippocampal long-term potentiation by FR121196, a putative cognitive enhancer. Matsuoka N; Yamaguchi I; Satoh M Eur J Pharmacol; 1993 Sep; 241(1):27-34. PubMed ID: 7901036 [TBL] [Abstract][Full Text] [Related]
6. FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action. Yamazaki M; Matsuoka N; Maeda N; Ohkubo Y; Yamaguchi I J Pharmacol Exp Ther; 1996 Dec; 279(3):1157-73. PubMed ID: 8968337 [TBL] [Abstract][Full Text] [Related]
7. Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Matsuoka N; Yamazaki M; Yamaguchi I Neuroscience; 1995 Jun; 66(3):617-26. PubMed ID: 7644025 [TBL] [Abstract][Full Text] [Related]
8. Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats. Ueki A; Miyoshi K J Neurol Sci; 1989 Mar; 90(1):1-21. PubMed ID: 2723670 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin. Schettini G; Florio T; Magri G; Grimaldi M; Meucci O; Landolfi E; Marino A Eur J Pharmacol; 1988 Jul; 151(3):399-407. PubMed ID: 2905659 [TBL] [Abstract][Full Text] [Related]
10. FK962, a novel enhancer of somatostatin release, exerts cognitive-enhancing actions in rats. Tokita K; Inoue T; Yamazaki S; Wang F; Yamaji T; Matsuoka N; Mutoh S Eur J Pharmacol; 2005 Dec; 527(1-3):111-20. PubMed ID: 16325809 [TBL] [Abstract][Full Text] [Related]
11. Working memory deficits following muscarinic blockade combined with depletion of brain somatostatin in rats. Ohno M; Shibata S; Yamamoto T; Watanabe S Brain Res; 1993 May; 610(2):348-53. PubMed ID: 8100474 [TBL] [Abstract][Full Text] [Related]
12. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Senda T; Matsuno K; Okamoto K; Kobayashi T; Nakata K; Mita S Eur J Pharmacol; 1996 Nov; 315(1):1-10. PubMed ID: 8960858 [TBL] [Abstract][Full Text] [Related]
13. Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats. Tokita K; Yamazaki S; Yamazaki M; Matsuoka N; Mutoh S Pharmacol Biochem Behav; 2002 Oct; 73(3):511-9. PubMed ID: 12151024 [TBL] [Abstract][Full Text] [Related]
14. Frontal cortex as the site of action of physostigmine in nbM-lesioned rats. Haroutunian V; Mantin R; Kanof PD Physiol Behav; 1990 Jan; 47(1):203-6. PubMed ID: 2326337 [TBL] [Abstract][Full Text] [Related]
15. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004 [TBL] [Abstract][Full Text] [Related]
16. Behavioral changes following central injection of cysteamine in rats. Bakhit C; Swerdlow N Brain Res; 1986 Feb; 365(1):159-63. PubMed ID: 2868783 [TBL] [Abstract][Full Text] [Related]
17. Involvement of raphe-hippocampal serotonergic and septo-hippocampal cholinergic mechanisms in the penile erection induced by FR121196, a putative cognitive enhancer. Maeda N; Matsuoka N; Yamazaki M; Yamaguchi I Jpn J Pharmacol; 1995 May; 68(1):85-94. PubMed ID: 7494387 [TBL] [Abstract][Full Text] [Related]
18. Is acetylcholine involved in memory consolidation of over-reinforced learning? Durán-Arévalo M; Cruz-Morales SE; Prado-Alcalá RA Brain Res Bull; 1990 Jun; 24(6):725-7. PubMed ID: 2372689 [TBL] [Abstract][Full Text] [Related]
19. Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry. Haroutunian V; Mantin R; Campbell GA; Tsuboyama GK; Davis KL Brain Res; 1987 Feb; 403(2):234-42. PubMed ID: 3828820 [TBL] [Abstract][Full Text] [Related]
20. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer. Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]